Pharmafile Logo
Pharmafocus logo
Advanced Search
dna image

Google diagnostic firm receives scathing FDA warning

November 26, 2013
Medical Communications, Research and Development, Sales and Marketing FDA, dna. 23andme, google

The Google-backed DNA testing firm 23andMe has received a warning letter from the FDA saying it cannot continue to market …

News
Unilife image

Hikma taps Unilife for pre-filled syringes

November 26, 2013
Manufacturing and Production Hikma, pre-filled, unilife

Jordanian drugmaker Hikma has signed a strategic-level deal with Unilife for the manufacture of generic injectable drugs using its pre-filled …

News

FDA U-turn on Avandia

November 26, 2013
Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2

The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …

News
william_mcculloch

3-V Biosciences hires chief medical officer

November 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 3V, biosciences, mcculloch

Clinical-stage biopharma firm 3-V Biosciences has taken on Dr William McCulloch as its chief medical officer.  McCulloch brings nearly three …

Appointment
NHS image

PPRS deal ‘dreadful’, says EMIG

November 26, 2013
Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

News
gsk image

GSK expands Montrose API plant with £25m investment

November 25, 2013
Manufacturing and Production GSK, Scotland, montrose

GlaxoSmithKline is planning to invest £25 million ($40m) at a facility in Scotland that will take on production of ingredients …

News
nexavar image

US regulator shows Nexavar green light

November 25, 2013
Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …

News

Cancer Research UK invests £100m in research centres

November 25, 2013
Research and Development, Sales and Marketing Cancer, Cancer Research UK, UK

Cancer Research UK says it will invest over £100 million across 15 cutting-edge research centres to help get new treatments …

News
janssen image

FDA approves Olysio

November 25, 2013
Sales and Marketing FDA, Janseen, Janssen, hep C, hepc, olysio, simeprevir

US regulators have approved Janssen Pharmaceuticals’ Olysio, a new therapy to treat chronic hepatitis C virus infection, after a priority …

News

Patient involvement ‘increases public confidence’ in research

November 25, 2013
Research and Development, Sales and Marketing hra, mori, public, rec, research

A new study has shown that public confidence in health research studies can be increased by knowing that patients have …

News
talent_pipeline

Hold your horses: M&A is about talent, not just pipelines

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent

The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …

Feature

Camargo Pharmaceutical Services names chief operating officer

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Camargo Pharmaceutical Services

Veteran healthcare executive Jim Beach has been named chief operating officer for drug development firm Camargo Pharmaceutical Services. “Jim’s history …

Appointment

Gilead gets CHMP nod

November 25, 2013
Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi

The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …

News

Pfizer says it will close Puerto Rico plant

November 22, 2013
Manufacturing and Production Guayama, Humacao, Pfizer, Puerto Rico, Vega Baja

News
NHS image

E-prescribing ‘patchy at best’

November 22, 2013
Medical Communications, Sales and Marketing DoH, NHS, UCL, e-prescribing

Electronic prescribing in NHS hospitals – seen as one of the cornerstones of public health provision in the future – …

News

Cancer app takes top prize in Janssen digital awards

November 22, 2013
Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare

A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …

News

Big data ‘road map’ launched by ABPI

November 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, BMA, NIHR, data, transparency

The ABPI has launched a new initiative that aims to harness the potential of big data to improve patient care …

News
screen_shot_2013-11-22_at_08

Life makes several changes

November 22, 2013
Medical Communications, Research and Development, Sales and Marketing Life, comms, creative, healthcare

Marketing communications firm Life is restructuring to advance its status as an integrated creative company. As part of this process …

Appointment
Department of health

Coalition launches rare disease strategy

November 22, 2013
Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease

The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …

News
lilly image

Lilly signs Lou Gehrig’s disease deal

November 21, 2013
Research and Development, Sales and Marketing als, hill, lilly, lou gehrig

Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026